Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000824626 | SCV000965531 | pathogenic | LAMA2-related muscular dystrophy | 2023-04-28 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individuals with autosomal recessive congenital muscular dystrophy (PMID: 9541105, 16216942, 30055037, 30147969). This sequence change creates a premature translational stop signal (p.Cys967*) in the LAMA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA2 are known to be pathogenic (PMID: 18700894, 32904964). This variant is present in population databases (rs121913577, gnomAD 0.002%). ClinVar contains an entry for this variant (Variation ID: 14301). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV001091209 | SCV001247104 | pathogenic | not provided | 2018-02-01 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV000015371 | SCV001367183 | pathogenic | Merosin deficient congenital muscular dystrophy | 2020-03-23 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS4,PM2,PP4. |
Baylor Genetics | RCV000015371 | SCV004190459 | pathogenic | Merosin deficient congenital muscular dystrophy | 2024-03-24 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000015371 | SCV000035632 | pathogenic | Merosin deficient congenital muscular dystrophy | 2005-10-01 | no assertion criteria provided | literature only | |
Gene |
RCV000015371 | SCV000054524 | not provided | Merosin deficient congenital muscular dystrophy | no assertion provided | literature only |